SCM
IMGN

Stevens Capital Management’s Immunogen Inc IMGN Stock Holding History

Stevens Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-11,757
Closed -$36K – 1194
2016
Q2 		$36K Buy
+11,757
New +$73.7K ﹤0.01% 865
2014
Q2 		– Sell
-10,125
Closed -$151K – 1365
2014
Q1 		$151K Buy
+10,125
New +$160K ﹤0.01% 968

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Stevens Capital Management's IMGN Position: Q3 2016 in Review

Stevens Capital Management sold out of Immunogen Inc (IMGN) in Q3 2016, closing a stake of 11,757 shares — an estimated $36K sold.

Stevens Capital Management first reported a position in IMGN in Q1 2014 and held it in 2 quarters. The position peaked at $151K in Q1 2014. 155 funds tracked by Wall St. Rank hold IMGN as of Q3 2016.

  • Stevens Capital Management reported no remaining Immunogen Inc position as of Q3 2016 after selling out during the quarter.
  • Stevens Capital Management sold 11,757 Immunogen Inc shares in Q3 2016, an estimated $36K.
  • Stevens Capital Management first reported a position in Immunogen Inc in Q1 2014 and held it in 2 quarters.
  • Stevens Capital Management's Immunogen Inc position peaked at $151K in Q1 2014.
  • 155 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2016.

Based on Stevens Capital Management's 13F filing for Q3 2016, filed 8 Nov 2016.